We work with the Myanmar Ministry of Health to provide care for HIV and TB patients, primary healthcare, and vaccinations.

Once the largest provider of HIV treatment in Myanmar, we are working with the Ministry of Health and Sports to transfer patients to the decentralised National AIDS Programme so they can receive care closer to home. This includes patients on treatment for co-infections such as hepatitis C, tuberculosis (TB) and multidrug-resistant TB (MDR-TB).

We have mobile teams in Naga, Sagaing, a remote, mountainous region in northern Myanmar, where communities have limited access to basic healthcare, especially during the rainy season, when some may be completely inaccessible for months.

Despite restrictions on humanitarian access to conflict-affected areas and forcibly displaced people, we also have mobile teams based in Sittwe, central Rakhine, offering primary healthcare and arranging emergency referrals for patients from all communities.

 
MSF Medical Action - Rohingya Crisis
Rohingya refugee crisis

Immediate action needed to avert massive public health disaster

Press Release 21 Sep 2017
 
Rohingyas Fleeing into Bangladesh
Rohingya refugee crisis

International humanitarian access to Rakhine State must urgently be permitted

Press Release 18 Sep 2017
 
Falling into the gap HIV+ adolescents - WAD 2016
Myanmar

Don't let adolescents with HIV slip away

Project Update 29 Nov 2016
 

Flood victims vulnerable to dengue fever

Project Update 17 Aug 2015
 
Myanmar

MSF assisting thousands as worst flooding in decades hits parts of the country

Project Update 4 Aug 2015
 
MDR-TB treatment MSF Clinic Yangon, Myanmar
Tuberculosis

The Luxury of MDR-TB treatment in Myanmar: An impossible choice for many

Voices from the Field 20 Mar 2015
 
Myanmar

MSF restarts basic medical activities in parts of Myanmar’s Rakhine State after nine-month absence

Press Release 20 Jan 2015
 
Myanmar

MSF welcomes offer to resume operations in Rakhine, Myanmar but remains cautious

Press Release 25 Jul 2014
 
Myanmar

First patients take oral drug for HIV-related blindness

Press Release 23 Jul 2014